Pricing Log in Create free account

Coya Therapeutics, Inc. (COYA) vs Milestone Pharmaceuticals Inc. (MIST)

Coya Therapeutics, Inc. and Milestone Pharmaceuticals Inc. are both Biotechnology companies. Coya Therapeutics, Inc. and Milestone Pharmaceuticals Inc. are of similar size ($101.8M and $98.9M). Coya Therapeutics, Inc. has the higher net margin (−270.2% vs −1,586.0%) and the lower return on invested capital (−15,230.9% vs 0.00%). Across the 16 metrics below, Coya Therapeutics, Inc. leads on 12 and Milestone Pharmaceuticals Inc. on 4.

Valuation

Metric COYA MIST Biotechnology median
P/E n/m n/m 8.50
P/S 12.49 18.59 9.71
P/B 2.31 5.41 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.16 0.64
EV/Sales 8.72 (2.44) 9.21
Earnings yield (25.06%) (97.18%) (33.15%)
Free cash flow yield (17.74%) (62.60%) (25.50%)

Profitability

Metric COYA MIST Biotechnology median
Gross margin 100.00% 13.27% 65.16%
Operating margin (288.70%) (1,479.69%) 0.00%
Net margin (270.22%) (1,586.01%) 0.00%
Free cash flow margin (221.64%) (1,163.79%) 0.00%
Return on equity (60.54%) (35,522.62%) (56.36%)
Return on assets (53.66%) (73.36%) (48.04%)
Return on invested capital (15,230.92%) 0.00% 0.00%

Growth

Metric COYA MIST Biotechnology median
Revenue growth (TTM) 108.35% — 6.02%
EPS growth (last fiscal year) (29.59%) (11.94%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COYA MIST Biotechnology median
Debt to equity 0.00 3.25 0.00
Current ratio 13.40 8.13 4.72
Net debt to EBITDA 2.08 0.79 0.96

Dividend

Metric COYA MIST Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric COYA MIST Biotechnology median
Market cap 101.80m 98.91m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack